{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:10:54Z","timestamp":1790136654804,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.dld.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T15:55:40Z","timestamp":1651420540000},"page":"737-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-6130","authenticated-orcid":false,"given":"Nicolas","family":"Benech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bonvalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Dufresne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Le P\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lopez-Trabada-Ataz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Meurgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayla","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Saurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2022.03.004_bib0001","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2022.03.004_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejca.2016.02.008","article-title":"Management of desmoid tumours: a nationwide survey of labelled reference centre networks in France","volume":"58","author":"Penel","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0004","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1634\/theoncologist.2010-0281","article-title":"Desmoid tumors: clinical features and treatment options for advanced disease","volume":"16","author":"Kasper","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.dld.2022.03.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60237-6","article-title":"Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis \u2013 a systematic analysis of 204 cases","volume":"10","author":"Trautmann","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2022.03.004_bib0006","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/gcc.22272","article-title":"Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis","volume":"54","author":"Crago","year":"2015","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/gcc.22644","article-title":"Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis","volume":"57","author":"Colombo","year":"2018","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0008","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/modpathol.2012.115","article-title":"CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics","volume":"25","author":"Le Guellec","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.dld.2022.03.004_bib0009","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10350-008-9232-5","article-title":"A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis","volume":"51","author":"Church","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2022.03.004_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2014.11.005","volume":"51","author":"Kasper","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0011","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/annonc\/mdx323","article-title":"An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between sarcoma patients EuroNet (SPAEN) and European organization for research and treatment of cancer (EORTC)\/soft tissue and bone sarcoma group (STBSG)","volume":"28","author":"Kasper","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0012","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/rg.2016150153","article-title":"Role of Imaging in management of desmoid-type fibromatosis: a primer for radiologists","volume":"36","author":"Braschi-Amirfarzan","year":"2016","journal-title":"Radiographics"},{"key":"10.1016\/j.dld.2022.03.004_bib0013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2214\/AJR.04.1674","article-title":"Aggressive fibromatosis: MRI features with pathologic correlation","volume":"186","author":"Lee","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.dld.2022.03.004_bib0014","doi-asserted-by":"crossref","first-page":"W1008","DOI":"10.2214\/AJR.11.6657","article-title":"A to Z of desmoid tumors","volume":"197","author":"Shinagare","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.dld.2022.03.004_bib0015","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1259\/bjr\/42420290","article-title":"Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state-of-the-art 1.5 T MRI better than 64-MDCT?","volume":"85","author":"Sinha","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.dld.2022.03.004_bib0017","doi-asserted-by":"crossref","first-page":"iv268","DOI":"10.1093\/annonc\/mdy321","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0018","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/DCR.0000000000000316","article-title":"Desmoids and genotype in familial adenomatous polyposis","volume":"58","author":"Church","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2022.03.004_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000381909","article-title":"Systemic treatment approaches for sporadic desmoid-type fibromatosis: scarce evidence and recommendations","volume":"38","author":"Kasper","year":"2015","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.dld.2022.03.004_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/gut.35.3.377","article-title":"Desmoid tumours in familial adenomatous polyposis","volume":"35","author":"Gurbuz","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.03.004_bib0021","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/hmg\/4.3.337","article-title":"Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444","volume":"4","author":"Caspari","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.dld.2022.03.004_bib0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/2050640616678150","article-title":"Management of desmoid tumours: a large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments","volume":"5","author":"Walter","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2022.03.004_bib0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1245\/s10434-016-5380-3","article-title":"Risk factors for the development of desmoid tumor after colectomy in patients with familial adenomatous polyposis: multicenter retrospective cohort study in Japan","volume":"23","author":"Saito","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0024","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1245\/s10434-018-07138-1","article-title":"Yield of colonoscopy in identification of newly diagnosed desmoid-type fibromatosis with underlying familial adenomatous polyposis","volume":"26","author":"van Houdt","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0002-9610(86)90076-0","article-title":"The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor","volume":"151","author":"Reitamo","year":"1986","journal-title":"Am J Surg"},{"key":"10.1016\/j.dld.2022.03.004_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.24117","article-title":"Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis","volume":"113","author":"Koskenvuo","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0027","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2350\/11-07-1064-OA.1","article-title":"CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm","volume":"15","author":"Wang","year":"2012","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.dld.2022.03.004_bib0028","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00000658-199906000-00014","article-title":"The enigma of desmoid tumors","volume":"229","author":"Lewis","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2022.03.004_bib0029","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejso.2007.06.006","article-title":"Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients","volume":"34","author":"Bonvalot","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0030","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1245\/s10434-009-0586-2","article-title":"Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment","volume":"16","author":"Fiore","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0031","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejca.2014.11.019","article-title":"Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients","volume":"51","author":"Colombo","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0032","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10549-019-05245-5","article-title":"Breast desmoid tumor management in France: toward a new strategy","volume":"176","author":"Duazo-Cassin","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.dld.2022.03.004_bib0033","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1245\/s10434-016-5159-6","article-title":"Toward observation as first-line management in abdominal desmoid tumors","volume":"23","author":"Burtenshaw","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0034","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors","volume":"379","author":"Gounder","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.03.004_bib0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaoncol.2018.6449","article-title":"Treatment of desmoid tumors in 2019","volume":"5","author":"Gronchi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0036","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1245\/s10434-013-3197-x","article-title":"Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought","volume":"20","author":"Bonvalot","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0037","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bjs.10477","article-title":"Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis","volume":"104","author":"Janssen","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2022.03.004_bib0038","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/annonc\/mdt254","article-title":"Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis\u2013an EORTC STBSG and ROG study (EORTC 62991-22998)","volume":"24","author":"Keus","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0039","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1200\/JCO.2009.25.5950","article-title":"Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study","volume":"28","author":"Nishida","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0040","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1056\/NEJMc1702562","article-title":"Desmoid tumors and celecoxib with sorafenib","volume":"376","author":"Benech","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.03.004_bib0041","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2017.06.017","article-title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group","volume":"83","author":"Penel","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0042","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO;2-Y","article-title":"Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis","volume":"92","author":"Azzarelli","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0043","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1111\/cas.14626","article-title":"Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: a phase II clinical trial","volume":"111","author":"Nishida","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.dld.2022.03.004_bib0044","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1158\/1078-0432.CCR-20-1847","article-title":"Long-term outcomes of oral vinorelbine in advanced, progressive desmoid fibromatosis and influence of CTNNB1 mutational status","volume":"26","author":"Mir","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2022.03.004_bib0045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S1470-2045(19)30276-1","article-title":"Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study","volume":"20","author":"Toulmonde","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0046","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients","volume":"127","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0047","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2020.10.035","article-title":"CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment","volume":"143","author":"Kurtz","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0048","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s11136-018-1931-3","article-title":"Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study","volume":"27","author":"Timbergen","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.dld.2022.03.004_bib0049","first-page":"965","article-title":"Desmoid fibromatosis through the patients\u2019 eyes: time to change the focus and organisation of care?","volume":"27","author":"Husson","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pon.5250","article-title":"High prevalence of persistent emotional distress in desmoid tumor","volume":"29","author":"Ingley","year":"2020","journal-title":"Psychooncology"},{"key":"10.1016\/j.dld.2022.03.004_bib0051","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bulcan.2015.02.001","article-title":"\u201cSOS Desmo\u00efde.\u201d pain burden in desmoid tumor patients: a survey of the French advocacy group SOS desmoid","volume":"102","author":"Rigaux","year":"2015","journal-title":"Bull Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0052","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/SLA.0000000000000224","article-title":"Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk","volume":"259","author":"Fiore","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2022.03.004_bib0053","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/bjs.9411","article-title":"Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis","volume":"101","author":"Vitellaro","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2022.03.004_bib0054","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2352-4642(17)30045-7","article-title":"The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series","volume":"1","author":"Orbach","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.dld.2022.03.004_bib0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.2006.08.2966","article-title":"Vinblastine and methotrexate for desmoid fibromatosis in children: results of a pediatric oncology group phase II trial","volume":"25","author":"Skapek","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0056","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ejso.2020.02.028","article-title":"Functional analysis of young patients with desmoid-type fibromatosis: initial surveillance does not jeopardize long term quality of life","volume":"46","author":"Duhil de B\u00e9naz\u00e9","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.dld.2022.03.004_bib0057","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-021-01320-1","article-title":"Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis","author":"Sparber-Sauer","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2022.03.004_bib0058","doi-asserted-by":"crossref","first-page":"e27472","DOI":"10.1002\/pbc.27472","article-title":"Evidence of hydroxyurea activity in children with pretreated desmoid-type fibromatosis: a new option in the armamentarium of systemic therapies","volume":"66","author":"Ferrari","year":"2019","journal-title":"Pediatr Blood Cancer"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:47Z","timestamp":1761625127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822002079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1590865822002079"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}